Jessica Ailani is a Neurology physician affiliated with Georgetown University. OpenAlex indexes 198 publications with 5,340 citations (h-index 33); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3800 Reservoir Rd NW
7-Phc
Washington, DC 200072113
Telephone
202-444-8525Registry record last updated 24 Feb 2012.
Clinical trials
- Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
Sponsor: Columbia University
- Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
Sponsor: Medstar Health Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202589 payments$75,011openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202518 payments$42,277openpaymentsdata.cms.gov ↗
- H. Lundbeck A SProgram year202511 payments$17,091openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
80.6%Neuromuscular Blocker80.5%Onabotulinumtoxina100%Botox0%Part D + Part B<11 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D<11 patients+ 2 more classes in this area
Nervous system
19.3%Calcitonin Gene-related Peptide Antagonist17.8%Eptinezumab-jjmr100%Part B, office-administered≥12 patientsCalcitonin gene-related peptide (CGRP) antagonists0.4%Aimovig Autoinjector71%Ajovy Autoinjector14%Emgality Pen14%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
0.1%Serotonin-3 Receptor Antagonist0.1%Ondansetron Odt100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group
Headache The Journal of Head and Face Pain
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Augusto Pichard, MD
Georgetown University
Virginia Steen
Georgetown University
Joseph Verbalis
Georgetown University
Craig Kessler
Georgetown University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”